|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06609 HEARTCARE-B
Nominal 
44.500 +0.400 (+0.907%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 277,899 | 232,344 | 183,032 | 90,089 |
| Cost of Sales | -- | -- | (96,183) | (68,585) | (58,699) | (35,139) |
| Gross Profit | -- | -- | 181,716 | 163,759 | 124,333 | 54,950 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | (32,008) | |
| Share of Results of Asso. & JCEs | -- | -- | 0 | 0 | (34,800) | 0 | |
| Profit / (Loss) before Taxation | -- | -- | (11,992) | (102,920) | (201,249) | (197,906) | |
| Taxation | -- | -- | (1,630) | 8,908 | 865 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 0 | 0 | 0 | 3,681 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 83,335 | -- | (13,622) | (94,012) | (200,384) | (194,225) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | (7,017) | (9,037) | (12,995) | (3,132) |
| Depreciation & Amortisation | -- | -- | 32,109 | 32,259 | 31,787 | 12,203 |
| Directors' Emoluments | -- | -- | 5,596 | 6,294 | 6,407 | 36,148 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 221.000 | -- | -36.000 | -247.000 | -524.000 | -582.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.086) | (2.322) | (6.970) | (6.164) |
| NBV per share ($) | -- | -- | 27.353 | 27.698 | 30.011 | 35.344 |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 83,335 |
| %Change | -- |
| EPS / (LPS) | RMB 2.210 |
| NBV Per Share (¥) | RMB -- |